
Shares of WORK Medical Technology Group LTD swung sharply in Tuesday’s premarket, after the U.S.-listed stock soared more than threefold on Monday. The move tracked news of an AI tie-up with Shanghai Novabioplus Biotechnology Co. The two firms aim to create medical models leveraging protein data and what WORK calls “BioTokens”—digital assets representing biological data.
Today’s highest-ranked model selections.
The catalysts most likely to move markets.
A large surprise can reset expectations for household spending and near-term growth, with read-through to Treasuries, USD and cyclical stocks.
Housing remains highly rate-sensitive; the print can move homebuilders, mortgage-sensitive names and the long end of the Treasury curve.
Guidance can influence software multiples and sentiment around U.S. small-business activity.